Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital

Literals

• ou:urlScopus
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85117349986&origin=inward
• ou:eid
  • 2-s2.0-85117349986
• dcterms:creator
  • Fricke-Galindo I.
• dcterms:contributor
  • Fricke-Galindo I.; Jung-Cook H.; Martinez-Juarez I.E.; Monroy-Jaramillo N.; Ortega-Vazquez A.; Rojas-Tome I.S.; Dorado P.; Penas-Lledo E.; Llerena A.; Lopez-Lopez M.
• bibo:doi
  • 10.2217/pgs-2021-0081
• ou:urlOrcid
  • https://doi.org/10.2217/pgs-2021-0081
• fabio:hasPublicationYear
  • 2021
• bibo:eissn
  • 1744-8042
• vivo:identifier
  • 2021-513
• bibo:issn
  • 1462-2416
• bibo:page_range
  • 983-996
• dcterms:publisher
  • Pharmacogenomics
• ou:tipoPublicacion
  • Article
• dcterms:title
  • Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital
• vcard:url
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85117349986&origin=inward
• ou:vecesCitado
  • 1
• bibo:volume
  • 22

Typed Literals

• dcterms:created
  • 2021-10-01T00:00:00 (xsd:dateTime)

Relations

• ou:publicadaEnRevista
  • PHARMACOGENOMICS

Inverse Relations

• Has related: ou:tienePublicacion
  • ADRIÁN LLERENA RUIZ
  • EVA MARÍA PEÑAS LLEDÓ
  • PEDRO DORADO HERNÁNDEZ